Dr Anna Kidman et al. compared higher vs lower NCPAP for extubation of extremely preterm infants (ÉCLAT) in a multi-centre, randomised trial buff.ly/3QglF6n Rosemarie Boland Brett J. Manley 🤷🏼‍♂️ Atul Malhotra The Lancet Child & Adolescent Health #ebneoalerts #neotwitter #NeoEBM

New RCT: Extubation of extremely #preterm infants to higher nCPAP significantly reduced extubation failure vs standard nCPAP, without increasing rates of adverse effects bit.ly/47cvPLZ #neoEBM

Incase anyone missed the publication of ÉCLAT authors.elsevier.com/c/1h~rR8Mut2Mz… have a read… 🤓

Well done Anup Katheria! Thorough and thought provoking research. A further step towards understanding appropriate cord management at birth! “There was no difference in the rates of severe IVH or death. UCM may be a safe alternative to DCC in premature infants born at 28 to 32 weeks”

Just fantastic! A huge congratulations to all involved in this important research 🫁

I’m obviously very biased as respiratory care is my flavour of choice but… FANTASTIC start to an exciting series 🫁 👶

Important ‼️

#neotwitter: For a 22 week 400g infant intubated in the delivery room, with minimal oxygen requirement, normal blood gases, spontaneous respiratory effort and no other major contraindications, I would attempt extubation:

Wow! What a way to start the new year after a break from social media! The ÈCLAT trial took a village! The work supporting respiratory support for preterm infants isn’t over yet! We only scratched the surface 🫁 🌟

Thank you for reviewing our trial!!